3623 results for «2557»
3623 results
Mitral replacement: expanding patient options, even mitral annular calcification!
18 May 2022 – From EUROPCR 2022
The objectives of this session from EuroPCR 2022 are to provide the best pathway for mitral regurgitation management, to learn about early commercial TMVR experience and to discover treatment options for mitral annular calcification patients.
Left main and complex bifurcation PCI in high bleeding risk patients
View the life challenging case of a 90-year-old male patient with a very active lifestyle but hypertension, dyslipidemia, ex-smoker, who presented with left main bifurcation lesion, and appreciate the value of transradial approach for left main and complex bifurcation PCI, acknowledge Ultimaster DES results in bifurcations and high...
EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary stenting: SORT OUT VIII, ROLEX, FANTOM II, and more!
18 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary stenting! FANTOM II trial, five-year follow-up in the SORT OUT VIII trial, impact of side branch disease pattern on outcome following left main PCI, intravascular imaging vs. angiography-guided PCI in high bleeding risk patients, safety and...
Cre8 EVO: the "sweetest advancement" that a diabetic patient is waiting for
18 May 2022 – From EuroPCR 2022
Thanks to a mix between cases and live lectures and discussions, this EuroPCR 2022 session will enable you to review the challenges of a PCI and the one-year results of the SUGAR RCT in diabetes mellitus patients, and to understand how to maximise PCI outcomes, especially by using Cre8 EVO...
Towards a personalised coronary intervention with CT-guided robotic-assisted PCI
17 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session aims to show how coronary CT angiography can help in pre-procedural planning and guidance of PCI to achieve the best patient outcomes. It also explores the role of robotic-assisted PCI in improving procedural accuracy, radiation safety, and ergonomics within the cathlab. Finally, it demonstrates how...
Start treating refractory angina patients with Reducer therapy - Practical aspects
17 May 2022 – From EuroPCR 2022
Looking at a 75-year-old male patient with HTA, diabetes, and hypothyroidism, a history of coronary artery disease treated with PCI of the RCA, and a previous coronary angiography showing preserved LVEF and in-stent restenosis of the RCA, you will learn in this EuroPCR 2022 session how...
Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation
17 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session, which covers the latest clinical evidence around catheter-based ultrasound renal denervation, will also enable you to appreciate the distinct features of this approach, to understand perspectives on patient selection and patient preference, and to learn how to introduce and establish interventional hypertension therapy.
DCB and the possibility of a clean vessel
17 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session aims to show, based on real-life cases, that even complex coronary disease can be treated without the need for permanent coronary stents. Learn how to prepare the vessel, deliver the therapy, and assess immediate outcomes after "DCB-alone" PCI, discuss de novo, small vessels, and...
The impact of the first transcatheter heart valve on the lifetime management of patients with aortic stenosis
18 May 2022 – From EUROPCR 2022
This session from EuroPCR 2022 will help you understand how the first bioprosthetic aortic valve may affect long-term outcomes of patients with aortic stenosis. Learn how to optimise their lifetime management and how to refine procedural steps during TAVI.
Double jeopardy: coronary disease in patients undergoing TAVI
17 May 2022 – From EuroPCR 2022
Through the presentation of real-life clinical cases, this session will allow you to discover the use of ALLEGRA for valve-in-valve TAVI, understand the management of coronary artery disease in TAVI patients, better detect when and how to protect coronary arteries during TAVI, or even learn how...
Leading clinical evidence while disrupting the mitral paradigm with clip therapy
17 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session with Nicole Karam, Stephan Baldus, Fabien Praz, Wolfgang Rottbauer, and Martin Swaans, and learn how the recent guidelines change the game in mitral disease management, how they can be implemented in practice, and what are the latest real-life clip data and...
How to deal with calcified CTO
17 May 2022 – From EuroPCR 2022
In this dedicated session from EuroPCR 2022, listen to Gabriele Luigi Gasparini talk about procedural challenges and device selection for calcified CTO, while James Spratt looks at how to deal with long, calcified CTO, and Kambis Mashayekhi discusses problems and solutions in calcified CTO.
How to select three-vessel disease patients eligible for PCI and guide the treatment by angiography-derived physiology
18 May 2022 – From EuroPCR 2022
What is angiographic SYNTAX score? Are 3VD all the same? What do ESC guidelines recommend? You will find answers to these questions, and many more, in this EuroPCR 2022 session, through which you will learn how to identify the right patient for three-vessel PCI, select the lesions to be...
EuroPCR 2022 Hotlines / Late-Breaking Trials in mitral and tricuspid: MITRA-TUNE, MitraBridge, TriCLASP, CLASP TR, and more!
19 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in mitral and tricuspid! MitraClip in atrial functional mitral regurgitation, two-year outcomes of MitraClip as a bridge to heart transplantation, TriCLASP post-market study, CLASP TR study one-year results, Cardioband TR early feasibility study, and initial 30-day results from...
The challenge of the diabetic patient with diffuse coronary artery disease: how physiology can simplify things
18 May 2022 – From EuroPCR 2022
Based on the didactic analysis of several practical cases, and also on the latest guidelines and study outcomes on the subject, learn in this EuroPCR 2022 session new management strategies to optimise PCI in diffuse coronary artery disease, new developments of the Optowire to support decision-making in patients...
Conquer calcium with intravascular lithotripsy (IVL): cases and clinical data
18 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session mainly focuses on the DISRUPT CAD studies: hear discussion on the latest DISRUPT CAD clinical evidence supporting the use of IVL across different calcium morphologies, appraise the most recent one-year OCT-pooled analysis of the DISRUPT CAD III and IV studies, and learn about the differences...
Angiography-derived physiological assessment of coronary artery stenosis severity and microvascular dysfunctions
18 May 2022 – From EuroPCR 2022
Follow the demonstrations of this EuroPCR 2022 session to understand the principles, clinical value, and applicability of coronary angiography-derived fractional flow reserve (caFFR), to discuss coronary angiography-derived index of microcirculatory resistance (caIMR) in the assessment of epicardial stenosis and coronary microcirculation, and to review data from available trials supporting these new...
EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!
19 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in drug-eluting balloons! A Sirolimus-coated balloon with micro-reservoir technology in coronary lesions, utilisation of DEB guided by post-PCI pressure gradient, DEB in combination with DES in the treatment of diffuse coronary artery disease,DEB for in-stent restenosis and plaque...
EuroPCR 2022 Hotlines / Late-Breaking Trials in TAVI: TRANSIT-PPM, LYTEN, SCOPE 2, and more!
18 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in TAVI! Balloon vs. self-expanding valves in valve-in-valve TAVI, trilogy for treatment of aortic regurgitation, management of Myocardial Revascularization in Patients with Stable Coronary Artery Disease Undergoing TAVI, SCOPE 2 subanalysis, prosthesis-patient mismatch following TAVR, and stroke complicating...
Embrace the innovation in PCI and TAVR: Robocath R-One vascular robot for PCI in China, MicroPort Firehawk TES stent, and VitaFlow valve
18 May 2022 – From EuroPCR 2022
The objective of this EuroPCR 2022 session is to highlight MicroPort's innovation portfolio in 3 different fields: learn more about the clinical performance of Firehawk Family stent in STEMI patients evaluated by imaging tools, the features and benefits of PCI robot R-ONE and first clinical trial updates in China,...
